Maravai Lifesciences Holdings Inc. (MRVI)
NASDAQ · Healthcare
Maravai Lifesciences Holdings Inc. EPS 2020–2025
Maravai Lifesciences Holdings Inc. annual/quarterly eps history and growth rate from 2020 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Maravai Lifesciences Holdings Inc. eps for the quarter ending March 31, 2026 was $0.02, a 90.48% decrease year-over-year.
- Maravai Lifesciences Holdings Inc. annual eps for 2025 was $0.90, a 14.29% decrease from 2024.
- Maravai Lifesciences Holdings Inc. annual eps for 2024 was $1.05, a 16.67% increase from 2023.
- Maravai Lifesciences Holdings Inc. annual eps for 2023 was $0.90, a 153.89% decrease from 2022.
- Maravai Lifesciences Holdings Inc. annual eps for 2022 was $1.67.
EPS
ANNUAL · USD
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Maravai Lifesciences Holdings Inc. EPS — FAQ
Maravai Lifesciences Holdings Inc. (MRVI) eps over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is Maravai Lifesciences Holdings Inc.'s eps?
Maravai Lifesciences Holdings Inc. (MRVI) reported eps of $-0.90 for fiscal 2025.
Where can I see MRVI's eps history?
The chart and table above show Maravai Lifesciences Holdings Inc.'s eps by year and by quarter, including the growth rate.